Kolexia
Ellis Stephen Oncologie radiothérapie
Ellis Stephen
Oncologie radiothérapie
Cl St Pierre Perpignan
Perpignan, France
40 Activités
4 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Carcinome intracanalaire non infiltrant Carcinome canalaire Tumeurs du sein Épithélioma in situ Tumeurs colorectales Carcinome adénoïde kystique Défaillance de prothèse Carcinome canalaire du sein

Collaborateurs

Voir plus
Cowen Didier
Cowen Didier
Clinique Chirurgicale De Martigues, Martigues, France
Azria David
Azria David
Icm Montpellier, Montpellier, France
Khemissa-Akouz Faiza
Khemissa-Akouz Faiza
Centre Hospitalier de Perpignan, Perpignan, France
Resbeut Michel
Resbeut Michel
Centre Paoli-Calmettes, Marseille, France

Industries

Voir plus
Lilly
9 collaboration(s)
Dernière en 2023
A+A
2 collaboration(s)
Dernière en 2022
MSD
1 collaboration(s)
Dernière en 2023
Parexel
1 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
LBA30 Panitumumab (P) + FOLFIRINOX or mFOLFOX6 in unresectable metastatic colorectal cancer (mCRC) patients (pts) with RAS/BRAF wild-type (WT) tumor status from circulating DNA (cirDNA): First results of the randomised phase II PANIRINOX-UCGI28 study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   24 septembre 2021
Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer.
JAMA network open   01 septembre 2021
Multicenter randomized phase II trial (BEVATOMOX) assessing the raltitrexed, oxaliplatin and bevacizumab combination versus FOLFOX6 bevacizumab as 2nd line treatment in metastatic colorectal cancer (mCRC)
Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8-12 September 2017, Madrid, Spain   01 septembre 2017
ERBB2 alterations a new prognostic biomarker in stage III colon cancer from a FOLFOX based adjuvant trial (PETACC8)
Abstract Book of the 41st ESMO Congress (ESMO 2016), 7-11 October 2016, Copenhagen, Denmark   01 octobre 2016
Influence du boost en curiethérapie dans la prise en charge des cancers du canal anal avec envahissement ganglionnaire initial (étude CORS-03)
23e Congrès national de la Société française de radiothérapie oncologique (SFRO)   01 septembre 2012
Adenoid cystic carcinoma of the head and neck: a retrospective series of 169 cases.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   29 mai 2012
OT2-06-01: A Phase III Randomized Multicentric French Study To Evaluate the Impact of a Localized 16-Gy Boost after Conservative Surgery and a 50-Gy Whole-Breast Irradiation in Breast Ductal Carcinoma In Situ (The BONBIS Trial).
Thirty-Fourth Annual CTRC AACR San Antonio Breast Cancer Symposium Dec 6 10, 2011   15 décembre 2011
Adenoid Cystic Carcinoma Of The Head and Neck: Retrospective Series Of 169 Cases
Proceedings of the American Society for Radiation Oncology 53rd Annual Meeting   01 octobre 2011
Phase III randomized French multicentric study to evaluate the impact of a localized 16-Gy boost after conservative surgery and a 50-Gy whole-breast irradiation in breast ductal carcinoma in situ (the BONBIS trial).
2011 ASCO Annual Meeting I   20 mai 2011